| Feb 25 | Feb 24 | Feb 23 | Feb 22 | Feb 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -1.39M | $ -1.34M | $ -916.29K | $ -976.66K | $ -1.30M |
| EBITDA | $ -1.39M | $ 0.00 | $ 0.00 | $ 0.00 | $ -1.20M |
| Net Income | $ -1.39M | $ -1.34M | $ -916.29K | $ -976.66K | $ -1.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 847.00 | $ 1.31K | $ 934.00 | $ 3.38K | $ 62.00 |
| Total Assets | $ 847.00 | $ 2.31K | $ 1.93K | $ 4.66K | $ 956.00 |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -847.00 | $ -1.31K | $ -934.00 | $ -3.38K | $ -62.00 |
| Total Liabilities | $ 42.48K | $ 27.43K | $ 15.66K | $ 3.46K | $ 46.80K |
| Stockholders' Equity | $ -41.64K | $ -25.12K | $ -13.73K | $ 1.21K | $ -45.84K |
| Cash Flow | |||||
| Free Cash Flow | $ -388.53K | $ -523.78K | $ -249.52K | $ -325.10K | $ -394.37K |
| Operating Cash Flow | $ -388.53K | $ -523.78K | $ -249.52K | $ -325.10K | $ -394.37K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 388.07K | $ 524.16K | $ 247.07K | $ 328.42K | $ 394.27K |
Burzynski Research Institute Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.